The creeping privatisation of NHS prescribing

BMJ 1994; 309 doi: 10.1136/bmj.309.6955.623 (Published 10 September 1994)
Cite this as: BMJ 1994;309:623

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. I Heath

    On 1 April this year the NHS prescription charge rose from pounds sterling 4.25 to pounds sterling 4.75. This was an increase of 11.8%, almost six times the rate of inflation, and the 16th rise in the prescription charge since 1979, producing a total rise of over 2000%. A total of pounds sterling300m is raised by prescription charges but the charge is paid for only one in five prescriptions. All the rest are provided to patients in one or other of the exempt categories.1 The burden of this particular form of indirect taxation is falling on a small minority of health service users.

    For some reason general practitioners responded to this particular rise in a way they had not done before: they began to issue private prescriptions to non-exempt patients whenever the cost of the medicines was less than the prescription charge. They were supported in this by many community pharmacists.2 Private prescriptions began to be issued on …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL